Visits: 1670, Avg visit time (secs): 246,69 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 737 | 44,13% | |
| /programmes.html | 148 | 8,86% |
| /novartis/efsd-novartis-rfa09.html | 114 | 6,83% |
| /msd/basic/efsd-msd-basic-rfa09.html | 105 | 6,29% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 97 | 5,81% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 44 | 2,63% |
| /efsd-grant/efsd-clinresgrant-rfa09.html | 37 | 2,22% |
| /msd/albert-renold/efsd-msd-arenold.html | 28 | 1,68% |
| /regulations.html | 27 | 1,62% |
| /lilly/programme/efsd-lilly-cds-fellowship08.html | 21 | 1,26% |
| /amylin/efsd-amylin-rfa08.html | 19 | 1,14% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 822 | 49,22% |
| /novartis/efsd-novartis-rfa09.html | 195 | 11,68% |
| /msd/basic/efsd-msd-basic-rfa09.html | 69 | 4,13% |
| /home.html | 48 | 2,87% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 44 | 2,63% |
| /dcure/efsd-dcure-rfa08.html | 33 | 1,98% |
| /msd/albert-renold/efsd-msd-arenold.html | 31 | 1,86% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 31 | 1,86% |
| /programmes.html | 30 | 1,80% |
| /new_horizons/new-horizons09.html | 28 | 1,68% |
| /gsk/efsd-gsk-rfa08.html | 27 | 1,62% |